4//SEC Filing
White Karen Ann 4
Accession 0001209191-23-036826
CIK 0001818331other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:25 PM ET
Size
13.7 KB
Accession
0001209191-23-036826
Insider Transaction Report
Form 4
White Karen Ann
Chief People Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2023-06-09+1,894→ 3,598 total - Sale
Class A Common Stock
2023-06-12$6.49/sh−828$5,374→ 2,770 total - Exercise/Conversion
Restricted Stock Unit
2023-06-09−1,894→ 26,515 total→ Class A Common Stock (1,894 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.10 to $6.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001874118
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:25 PM ET
- Size
- 13.7 KB